Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125201362 | 12520136 | 2 | F | 20150529 | 20160715 | 20160630 | 20160719 | EXP | IE-AMGEN-IRLSL2015061496 | AMGEN | 57.00 | YR | A | F | Y | 0.00000 | 20160718 | MD | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125201362 | 12520136 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, POST CHEMOTHERAPY 3 WEEKLY CYCLE | 1052486A | 125031 | 6 | MG | SOLUTION FOR INJECTION | Q3W | |||||
| 125201362 | 12520136 | 2 | SS | NEUPOGEN | FILGRASTIM | 1 | Unknown | UNK, POST FIRST CYCLE OF TREATMENT | U | 0 | UNKNOWN FORMULATION | ||||||||
| 125201362 | 12520136 | 3 | C | SENOKOT | SENNOSIDES | 1 | Other | 2 MG, PRN (AS REQUIRED) | 0 | 2 | MG | ||||||||
| 125201362 | 12520136 | 4 | C | MOTILIUM | DOMPERIDONE | 1 | Other | 10 MG, PRN (AS REQUIRED) | 0 | 10 | MG | ||||||||
| 125201362 | 12520136 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Other | 4 MG, AS PER CHEMO PRESCRIPTION | 0 | 4 | MG | ||||||||
| 125201362 | 12520136 | 6 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Other | 10 MG, BD | 0 | 10 | MG | BID | |||||||
| 125201362 | 12520136 | 7 | C | VALOID | CYCLIZINE HYDROCHLORIDE | 1 | Other | 50 MG, PRN (AS REQUIRED) | 0 | 50 | MG | ||||||||
| 125201362 | 12520136 | 8 | C | LYRICA | PREGABALIN | 1 | Other | 75 MG, B.D | 0 | 75 | MG | BID | |||||||
| 125201362 | 12520136 | 9 | C | OXYNORM | OXYCODONE HYDROCHLORIDE | 1 | Other | 5 MG, PRN (AS REQUIRED) | 0 | 5 | MG | ||||||||
| 125201362 | 12520136 | 10 | C | ELTROXIN | LEVOTHYROXINE | 1 | Other | 150 MUG, ON ALTERNATE DAYS | 0 | 150 | UG | ||||||||
| 125201362 | 12520136 | 11 | C | ELTROXIN | LEVOTHYROXINE | 1 | 150 MUG, ONCE DAILY | 0 | 100 | UG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125201362 | 12520136 | 1 | Breast cancer |
| 125201362 | 12520136 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125201362 | 12520136 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125201362 | 12520136 | Arthralgia | |
| 125201362 | 12520136 | Bone pain | |
| 125201362 | 12520136 | Erythema | |
| 125201362 | 12520136 | Flank pain | |
| 125201362 | 12520136 | Malaise | |
| 125201362 | 12520136 | Oral mucosal blistering |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125201362 | 12520136 | 1 | 20150528 | 0 |